Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply

JAMA Cardiol. 2018 Sep 1;3(9):897-898. doi: 10.1001/jamacardio.2018.2382.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amides
  • Benzodiazepines
  • Case-Control Studies
  • Esters
  • Genotype
  • Humans
  • Sulfhydryl Compounds
  • Vascular Diseases*

Substances

  • Amides
  • Esters
  • Sulfhydryl Compounds
  • Benzodiazepines
  • dalcetrapib
  • evacetrapib